ibuprofen and Flatus
ibuprofen has been researched along with Flatus in 1 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| " Vital signs, adverse events, and pain scores were assessed." | 2.80 | The shortened infusion time of intravenous ibuprofen, part 2: a multicenter, open-label, surgical surveillance trial to evaluate safety. ( Bergese, SD; Buvanendran, A; Candiotti, K; Gan, TJ; Philip, BK; Soghomonyan, S; Turan, A; Viscusi, ER, 2015) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Gan, TJ | 1 |
| Candiotti, K | 1 |
| Turan, A | 1 |
| Buvanendran, A | 1 |
| Philip, BK | 1 |
| Viscusi, ER | 1 |
| Soghomonyan, S | 1 |
| Bergese, SD | 1 |
Clinical Trials (2)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-Center, Open-Label, Surgical Surveillance Trial To Evaluate The Safety And Efficacy Of A Shortened Infusion Time of Intravenous Ibuprofen[NCT01334957] | Phase 4 | 300 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
| Comparison of the Postoperative Analgesia Effectiveness of Preemptive Intravenous Ibuprofen and Paracetamol in Patients Undergoing Laparoscopic Cholecystectomy[NCT03063658] | Phase 4 | 108 participants (Anticipated) | Interventional | 2017-02-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Trial Outcomes
To Determine the Safety of a Multiple Doses of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Reduction of Post-operative Pain.
"Visual Analog Scale (VAS) assessments following surgery. The VAS is a continuous scale compromised of a horizontal line, one hundred millimeters in length, anchored by 2 verbal descriptors (No Pain, Worst Possible Pain). The VAS is self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity. Using a ruler, the score is determined by measuring the distance, in mm, on the 100 mm line between the No Pain anchor and the subject's mark. The score would be between o and 100." (NCT01334957)
Timeframe: 6 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Intravenous Ibuprofen | 30.9 |
To Determine the Safety of a Multiple Doses of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Reduction of Post-operative Pain.
The incidence of treatment-emergent adverse events occurring in the six hours following administration of the last dose of intravenous ibuprofen (NCT01334957)
Timeframe: 6 hours
| Intervention | Number of Adverse Events (Number) |
|---|---|
| Intravenous Ibuprofen | 16 |
To Determine the Safety of a Multiple Doses of Intravenous Ibuprofen Over 5-10 Minutes for the Reduction of Pain.
The incidence of treatment-emergent serious adverse events occurring in the six hours following administration of the last dose of intravenous ibuprofen (NCT01334957)
Timeframe: 6 hours
| Intervention | Number of Serious Adverse Events (Number) |
|---|---|
| Intravenous Ibuprofen | 0 |
To Determine the Safety of a Single Dose of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Reduction of Post-operative Pain.
The incidence of treatment-emergent adverse events occurring in the six hours following administration of the first dose of intravenous ibuprofen (NCT01334957)
Timeframe: 6 hours
| Intervention | Number of Adverse Events (Number) |
|---|---|
| Intravenous Ibuprofen | 49 |
To Determine the Safety of a Single Dose of Intravenous Ibuprofen Over 5-10 Minutes for the Reduction of Pain.
The incidence of treatment-emergent serious adverse events occurring in the six hours following administration of the first dose of intravenous ibuprofen (NCT01334957)
Timeframe: 6 hours
| Intervention | Number of Serious Adverse Events (Number) |
|---|---|
| Intravenous Ibuprofen | 8 |
Trials
1 trial available for ibuprofen and Flatus
| Article | Year |
|---|---|
The shortened infusion time of intravenous ibuprofen, part 2: a multicenter, open-label, surgical surveillance trial to evaluate safety.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug | 2015 |
The shortened infusion time of intravenous ibuprofen, part 2: a multicenter, open-label, surgical surveillance trial to evaluate safety.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug | 2015 |
The shortened infusion time of intravenous ibuprofen, part 2: a multicenter, open-label, surgical surveillance trial to evaluate safety.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug | 2015 |
The shortened infusion time of intravenous ibuprofen, part 2: a multicenter, open-label, surgical surveillance trial to evaluate safety.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug | 2015 |